• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无Δ9-四氢大麻酚的大麻二酚对犬特应性皮炎的影响:8 例回顾性评估。

Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.

机构信息

Department of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan (Mogi, Fukuyama); Hidamari Animal Hospital, Kanagawa, Japan (Yoshida); Tokyo Animal Allergy Center, Tokyo, Japan (Kawano); Department of Veterinary Science, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan (Arai).

出版信息

Can Vet J. 2022 Apr;63(4):423-426.

PMID:35368394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8922375/
Abstract

OBJECTIVE

We aimed to examine the effects of cannabidiol (CBD)-containing hemp oil without delta-9-tetrahydrocannabinol (THC) as a supplemental treatment for canine atopic dermatitis (CAD), as well as its adverse effects, and effects on concurrent drug use in dogs.

ANIMAL

In this retrospective case series, 8 dogs with CAD were diagnosed by veterinary dermatologists certified by the Japanese Society of Veterinary Dermatology.

PROCEDURE

The medical records of dogs supplemented with CBD-containing hemp oil were evaluated with respect to signalment, physical examination, plasma C-reactive protein concentrations, pharmacologic management, the CAD Extent and Severity Index (4th iteration), and the Pruritus Visual Analog Scale.

RESULTS

Overall, CBD, used as a supplement in combination with other drugs, was well-tolerated over a wide dose range and decreased the occurrence of pruritus in dogs with CAD when ingested twice a day.

CONCLUSION

This study provides the first report of supplementation with CBD without THC that was effective in controlling pruritic behavior in dogs with CAD.

CLINICAL RELEVANCE

Further controlled studies are required to investigate the dose range, efficacy, and safety.

摘要

目的

本研究旨在探讨不含Δ9-四氢大麻酚(THC)的大麻二酚(CBD) Hemp 油作为犬特应性皮炎(CAD)辅助治疗的效果、不良反应以及对同时使用的药物的影响。

动物

在这项回顾性病例系列研究中,由日本兽医皮肤病学会认证的兽医皮肤科医生诊断了 8 只 CAD 犬。

程序

评估了补充 CBD Hemp 油的犬的病历,包括品种、体格检查、血浆 C 反应蛋白浓度、药物管理、CAD 严重程度和严重程度指数(第 4 次迭代)和瘙痒视觉模拟量表。

结果

总体而言,CBD 作为补充剂与其他药物联合使用时,在较宽的剂量范围内具有良好的耐受性,并且当每天摄入两次时,可减少 CAD 犬的瘙痒发生。

结论

本研究首次报道了 CBD 补充剂可有效控制 CAD 犬的瘙痒行为,且不含有 THC。

临床相关性

需要进一步的对照研究来调查剂量范围、疗效和安全性。

相似文献

1
Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.无Δ9-四氢大麻酚的大麻二酚对犬特应性皮炎的影响:8 例回顾性评估。
Can Vet J. 2022 Apr;63(4):423-426.
2
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis.含大麻二酚和大麻二酚酸的油对患有特应性皮炎的犬只的影响。
Vet Dermatol. 2022 Aug;33(4):329-e77. doi: 10.1111/vde.13077. Epub 2022 May 29.
3
Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.用于评估接受医用大麻治疗犬癫痫的犬只体内Δ9-四氢大麻酚和大麻二酚的简单快速气相色谱-质谱分析法
Curr Pharm Biotechnol. 2017;18(10):821-827. doi: 10.2174/1389201018666171122115815.
4
Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.Δ9-四氢大麻酚和大麻二酚的治疗用途:一种制备大麻基橄榄油的新提取方法的评估
Curr Pharm Biotechnol. 2017;18(10):828-833. doi: 10.2174/1389201019666171129175655.
5
A randomised, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis.一项随机、双盲、对照临床试验,旨在确定奥昔替尼与海洋油提取物 PCSO-524 联合治疗过敏性皮炎犬的疗效。
Vet Dermatol. 2023 Dec;34(6):523-531. doi: 10.1111/vde.13193. Epub 2023 Jul 23.
6
Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles.经皮给予低四氢大麻酚大麻二酚提取物后比格犬血清中大麻二酚、四氢大麻酚及其天然酸衍生物浓度。
J Vet Pharmacol Ther. 2020 Sep;43(5):508-511. doi: 10.1111/jvp.12896. Epub 2020 Jul 31.
7
A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine-month controlled study.在一项为期九个月的对照研究中,一种新的治疗性饮食可显著降低特应性皮炎犬的药物评分和瘙痒。
Vet Dermatol. 2022 Feb;33(1):55-e18. doi: 10.1111/vde.13020. Epub 2021 Sep 20.
8
Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.伴用泼尼松龙和环孢素 A 的短期联合治疗可加速犬特应性皮炎瘙痒的缓解和临床评分的改善。
BMC Vet Res. 2013 Sep 3;9:173. doi: 10.1186/1746-6148-9-173.
9
Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.西地那非在犬体内的药代动力学:一种潜在的基于大麻素的犬科疾病治疗方法。
Biomolecules. 2020 Feb 11;10(2):279. doi: 10.3390/biom10020279.
10
Hair cortisol concentration, disease severity and quality of life in dogs with atopic dermatitis during lokivetmab therapy.患有特应性皮炎的犬在接受洛维昔单抗治疗期间的毛发皮质醇浓度、疾病严重程度和生活质量。
Vet Dermatol. 2023 Aug;34(4):339-347. doi: 10.1111/vde.13151. Epub 2023 May 11.

引用本文的文献

1
Anti-Inflammatory Activity of L. Extract in 2,4-Dinitrochlorobenzene-Induced Dermatitis in Rats.L提取物对2,4-二硝基氯苯诱导的大鼠皮炎的抗炎活性。
Pharmaceuticals (Basel). 2025 Mar 5;18(3):370. doi: 10.3390/ph18030370.
2
The Potential of Cannabidiol for Treating Canine Atopic Dermatitis.大麻二酚治疗犬特应性皮炎的潜力。
Vet Sci. 2025 Feb 12;12(2):159. doi: 10.3390/vetsci12020159.
3
CBD for pets: navigating quality assurance, safety standards, and marketing strategies.宠物用大麻二酚:把握质量保证、安全标准及营销策略。
J Cannabis Res. 2025 Jan 23;7(1):6. doi: 10.1186/s42238-024-00257-5.
4
Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review.内源性大麻素系统和植物大麻素在主要具有兽医应用价值的物种中的应用:比较综述。
Vet Res Commun. 2024 Oct;48(5):2915-2941. doi: 10.1007/s11259-024-10509-7. Epub 2024 Aug 20.
5
Danish dog owners' use and the perceived effect of unlicensed cannabis products in dogs.丹麦狗主人对未获许可的大麻产品在狗身上的使用及其感知效果。
PLoS One. 2024 Jan 31;19(1):e0296698. doi: 10.1371/journal.pone.0296698. eCollection 2024.
6
Behavioral observations, heart rate and heart rate variability in horses following oral administration of a cannabidiol containing paste in three escalating doses (part 1/2).马匹口服含三种递增剂量大麻二酚的膏剂后的行为观察、心率及心率变异性(第1部分/共2部分)
Front Vet Sci. 2023 Dec 11;10:1305868. doi: 10.3389/fvets.2023.1305868. eCollection 2023.
7
Dermatological evaluation in dogs with atopic dermatitis treated with full-spectrum high cannabidiol oil: a pre study part 1.用全谱高大麻二酚油治疗的特应性皮炎犬的皮肤病学评估:一项预研究的第1部分。
Front Vet Sci. 2023 Oct 31;10:1285384. doi: 10.3389/fvets.2023.1285384. eCollection 2023.
8
Canine immune cells express high levels of CB and CB cannabinoid receptors and cannabinoid-mediated alteration of canine cytokine production is vehicle-dependent.犬的免疫细胞表达高水平的 CB 和 CB 大麻素受体,大麻素介导的犬细胞因子产生的改变依赖于载体。
Vet Immunol Immunopathol. 2023 Nov;265:110667. doi: 10.1016/j.vetimm.2023.110667. Epub 2023 Oct 31.
9
Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses.口服大麻二酚的药代动力学建模及其对马匹药物控制的影响。
Front Vet Sci. 2023 Aug 9;10:1234551. doi: 10.3389/fvets.2023.1234551. eCollection 2023.
10
Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge.犬用大麻二酚的药代动力学、疗效及安全性:现有知识更新
Front Vet Sci. 2023 Jun 30;10:1204526. doi: 10.3389/fvets.2023.1204526. eCollection 2023.

本文引用的文献

1
Evaluation of Plasma C-Reactive Protein as a Biomarker in Dogs with Atopic -Dermatitis Receiving Allergen-Specific Immunotherapy: A Pilot Study.评价过敏-特应性皮炎患犬接受过敏原特异性免疫治疗时血浆 C-反应蛋白作为生物标志物的价值:一项初步研究。
Schweiz Arch Tierheilkd. 2021 Jan;163(1):67-72. doi: 10.17236/sat00287.
2
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.使用医用和消费级大麻二酚(CBD)时潜在的药物不良事件和药物相互作用。
J Clin Med. 2019 Jul 8;8(7):989. doi: 10.3390/jcm8070989.
3
Role of C-Reactive Protein at Sites of Inflammation and Infection.C-反应蛋白在炎症和感染部位的作用。
Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754. eCollection 2018.
4
Cannabidiol: State of the art and new challenges for therapeutic applications.大麻二酚:治疗应用的最新技术和新挑战。
Pharmacol Ther. 2017 Jul;175:133-150. doi: 10.1016/j.pharmthera.2017.02.041. Epub 2017 Feb 22.
5
Cannabinoids and Cytochrome P450 Interactions.大麻素与细胞色素P450的相互作用。
Curr Drug Metab. 2016;17(3):206-26. doi: 10.2174/1389200217666151210142051.
6
An update on the treatment of canine atopic dermatitis.犬特应性皮炎治疗的最新进展。
Vet J. 2016 Jan;207:29-37. doi: 10.1016/j.tvjl.2015.09.016. Epub 2015 Sep 16.
7
Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis.评估依曲珠单抗在中度至重度活动性溃疡性结肠炎患者中与疾病相关的治疗性蛋白质药物相互作用
J Clin Pharmacol. 2016 Jun;56(6):693-704. doi: 10.1002/jcph.649. Epub 2016 Jan 11.
8
Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.犬特应性皮炎范围和严重程度指数(CADESI)-4的验证,这是一种用于评估犬特应性皮炎皮肤病变的简化严重程度量表。
Vet Dermatol. 2014 Apr;25(2):77-85, e25. doi: 10.1111/vde.12107. Epub 2014 Jan 25.
9
New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.特应性皮炎发病机制新概念:屏障、过敏和瘙痒相互作用的三联征。
J Dermatol Sci. 2013 Apr;70(1):3-11. doi: 10.1016/j.jdermsci.2013.02.001. Epub 2013 Feb 15.
10
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis.健康犬和特应性皮炎犬皮肤中1型和2型大麻素受体的表达
Am J Vet Res. 2012 Jul;73(7):988-95. doi: 10.2460/ajvr.73.7.988.